Literature DB >> 16093362

Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease.

Dolores Vernet1, Gaby Nolazco, Liliana Cantini, Thomas R Magee, Ansha Qian, Jacob Rajfer, Nestor F Gonzalez-Cadavid.   

Abstract

Tissue ossification in Peyronie disease (commonly known as Peyronie's disease [PD]), a localized fibrotic lesion within the tunica albuginea (TA) of the penis, may result from osteogenic differentiation of fibroblasts, myofibroblasts, and/or adult stem cells in the TA, and may be triggered by chronic inflammation, oxidative stress, and profibrotic factors like transforming growth factor beta 1 (TGFB1). In this study, we have investigated whether cultures of cells from normal TA and PD plaques undergo osteogenesis, express markers for stem cells, and originate other cell lineages via processes modulated by TGFB1. We found that TA and PD cells in osteogenic medium (OM) expressed osteogenic markers, alkaline phosphatase, and osteopontin and underwent calcification. PD cells, but not TA cells, formed foci in soft agar that were positive for alkaline phosphatase and calcification and expressed the mRNAs for osteoblast-specific factors pleiotrophin and periostin and bone morphogenic protein 2. Both cultures expressed stem cell marker CD34 antigen but not protein tyrosine phosphatase, receptor type c. TA and PD cells expressed smooth-muscle cell markers smoothelin and transgelin. None of the cultures underwent adipogenesis in adipogenic medium. Incubation with TGFB1 increased osteogenesis and myofibroblast differentiation and reduced CD34 antigen expression in both cultures. TA and PD cells modulated the differentiation of the multipotent C3H 10T(1/2) cells in dual cultures, into osteoblasts and myofibroblasts. In conclusion, both TA and PD cultures contain cells, presumably stem cells, that undergo osteogenic and myofibroblast differentiation, and may induce these processes by paracrine interactions. This may explain progression of fibrosis in the PD plaque and its eventual calcification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093362     DOI: 10.1095/biolreprod.105.041038

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  20 in total

Review 1.  Stem cells: novel players in the treatment of erectile dysfunction.

Authors:  Haiyang Zhang; Maarten Albersen; Xunbo Jin; Guiting Lin
Journal:  Asian J Androl       Date:  2011-10-17       Impact factor: 3.285

2.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

3.  Isolation and passage of muscle-derived stem cells from the rat penile corpora cavernosa and induction of differentiation into smooth muscle cells.

Authors:  Li-Jun Xu; Bo-Xin Xue; Dong Chen; Jie Gao; Dong-Rong Yang; Chuan-Yang Sun; Yong Cui; Yu-Xi Shan
Journal:  Cytotechnology       Date:  2013-11-19       Impact factor: 2.058

Review 4.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

5.  Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture.

Authors:  Maryam Masouminia; Robert Gelfand; Istvan Kovanecz; Dolores Vernet; James Tsao; Ruben Salas; Kenny Castro; Leila Loni; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2018-12       Impact factor: 3.802

6.  Intratunical injection of autologous adipose stromal vascular fraction reduces collagen III expression in a rat model of chronic penile fibrosis.

Authors:  Lukman Hakim; Salvatore Fiorenzo; Petter Hedlund; Francesco Montorsi; Trinity J Bivalacqua; Dirk De Ridder; Emmanuel Weyne; David Ralph; Giulio Garaffa; Asif Muneer; Steven Joniau; Maarten Albersen; Fabio Castiglione
Journal:  Int J Impot Res       Date:  2019-04-15       Impact factor: 2.896

7.  Pentoxifylline treatment and penile calcifications in men with Peyronie's disease.

Authors:  James F Smith; Alan W Shindel; Yun-Ching Huang; Raul I Clavijo; Lawrence Flechner; Benjamin N Breyer; Michael L Eisenberg; Tom F Lue
Journal:  Asian J Androl       Date:  2010-11-22       Impact factor: 3.285

8.  The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.

Authors:  Robert A Gelfand; Dolores Vernet; Istvan Kovanecz; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2014-12-11       Impact factor: 3.802

9.  Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds.

Authors:  Matthew H Ho; Sanaz Heydarkhan; Dolores Vernet; Istvan Kovanecz; Monica G Ferrini; Narender N Bhatia; Nestor F Gonzalez-Cadavid
Journal:  Obstet Gynecol       Date:  2009-08       Impact factor: 7.661

10.  Presence of stem/progenitor cells in the rat penis.

Authors:  Guiting Lin; Amjad Alwaal; Xiaoyu Zhang; Jianwen Wang; Lin Wang; Huixi Li; Guifang Wang; Hongxiu Ning; Ching-Shwun Lin; Zhongcheng Xin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2015-01-15       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.